Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Kidney Medicine, 2022Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay
Schmidt I., Colona M., Srivastava A. et al.
Olink Target 96
Scandinavian Journal of Immunology, 2022The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes
Ljunggren H., Heggernes Ask E., Cornillet M. et al.
Nature Communications, 2022Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer
Liu J., Wang Y., Tian Z. et al.
Journal of the American College of Cardiology, 2022Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
Tayal U., Verdonschot J., Hazebroek M. et al.
Annals of Oncology, 2022Impact of acetaminophen on the efficacy of immunotherapy in cancer patients
Bessede A., Marabelle A., Guégan J. et al.
Multiple Sclerosis and Related Disorders, 2022Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL
Gawde S., Agasing A., Bhatt N. et al.
Atherosclerosis, 2022Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach
Shafi B., Bøttcher M., Ejupi A. et al.
Molecular Psychiatry, 2022Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
Mätlik K., Garton D., Montaño-Rodríguez A. et al.
Annals of the Rheumatic Diseases, 2022Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus
Dörner T., Tanaka Y., Dow E. et al.
Osteoporosis International, 2022Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial
Sköld C., Kultima K., Freyhult E. et al.
Thorax, 2022Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant
Heydarian M., Oak P., Zhang X. et al.
PLOS ONE, 2022Genetically regulated gene expression and proteins revealed discordant effects
Pott J., Garcia T., Hauck S. et al.
PROTEOMICS, 2022Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms
Haslam D., Li J., Dillon S. et al.
eBioMedicine, 2022The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
Jones D., Wetten A., Barron-Millar B. et al.
European Journal of Heart Failure, 2022Distinct pathophysiological pathways in women and men with heart failure
Ravera A., Santema B., de Boer R. et al.
Clinical Kidney Journal, 2022Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes
Laursen J., Søndergaard-Heinrich N., Haddock B. et al.
Scientific Reports, 2022Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction
Girerd N., Cleland J., Anker S. et al.
Pediatric Research, 2022Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Kindt A., Förster K., Cochius-den Otter S. et al.
Scientific Reports, 2022Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome
Niroomand A., Ghaidan H., Hallgren O. et al.
eBioMedicine, 2022Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet
Dahlin M., Singleton S., David J. et al.
1945 publications
Items per page
1021-1040 of 1945 publications